Rituxan/ MabThera (Rituximab)

Biosimilar Characterization Considerations

Structural Characterization

Physicochemical Characterization

Functional Testing by Custom Biologics

  • Antibody-Dependent Cell Cytotoxicity (ADCC) Reporter Bioassay
  • Complement-Dependent Cytotoxicity (CDC) Assay
  • Binding Assays – CD20, Fc-Receptors, C1q
    • ELISA
    • MSD
    • BLI

Product Specific Technical Considerations

Need Biosimilar Testing?